JP2020533319A5 - - Google Patents

Download PDF

Info

Publication number
JP2020533319A5
JP2020533319A5 JP2020513872A JP2020513872A JP2020533319A5 JP 2020533319 A5 JP2020533319 A5 JP 2020533319A5 JP 2020513872 A JP2020513872 A JP 2020513872A JP 2020513872 A JP2020513872 A JP 2020513872A JP 2020533319 A5 JP2020533319 A5 JP 2020533319A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
compound
halo
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020513872A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020533319A (ja
JP7273030B2 (ja
JP7273030B6 (ja
Filing date
Publication date
Priority claimed from CN201710801364.3A external-priority patent/CN109467538A/zh
Application filed filed Critical
Publication of JP2020533319A publication Critical patent/JP2020533319A/ja
Publication of JP2020533319A5 publication Critical patent/JP2020533319A5/ja
Priority to JP2023072737A priority Critical patent/JP7603740B2/ja
Publication of JP7273030B2 publication Critical patent/JP7273030B2/ja
Application granted granted Critical
Publication of JP7273030B6 publication Critical patent/JP7273030B6/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020513872A 2017-09-07 2018-09-07 シクロオレフィン置換複素芳香族化合物およびそれらの使用 Active JP7273030B6 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023072737A JP7603740B2 (ja) 2017-09-07 2023-04-26 シクロオレフィン置換複素芳香族化合物およびそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201710801364.3 2017-09-07
CN201710801364.3A CN109467538A (zh) 2017-09-07 2017-09-07 环烯烃取代的杂芳环类化合物及其用途
PCT/CN2018/104531 WO2019047909A1 (en) 2017-09-07 2018-09-07 HETEROAROMATIC COMPOUNDS SUBSTITUTED WITH CYCLOOLEFINS AND THEIR USE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023072737A Division JP7603740B2 (ja) 2017-09-07 2023-04-26 シクロオレフィン置換複素芳香族化合物およびそれらの使用

Publications (4)

Publication Number Publication Date
JP2020533319A JP2020533319A (ja) 2020-11-19
JP2020533319A5 true JP2020533319A5 (enExample) 2021-10-14
JP7273030B2 JP7273030B2 (ja) 2023-05-12
JP7273030B6 JP7273030B6 (ja) 2024-02-15

Family

ID=65634832

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020513872A Active JP7273030B6 (ja) 2017-09-07 2018-09-07 シクロオレフィン置換複素芳香族化合物およびそれらの使用
JP2023072737A Active JP7603740B2 (ja) 2017-09-07 2023-04-26 シクロオレフィン置換複素芳香族化合物およびそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023072737A Active JP7603740B2 (ja) 2017-09-07 2023-04-26 シクロオレフィン置換複素芳香族化合物およびそれらの使用

Country Status (20)

Country Link
US (3) US11414390B2 (enExample)
EP (1) EP3679020A4 (enExample)
JP (2) JP7273030B6 (enExample)
KR (1) KR102566237B1 (enExample)
CN (6) CN109467538A (enExample)
AR (1) AR112794A1 (enExample)
AU (1) AU2018329047B2 (enExample)
BR (1) BR112020004563A2 (enExample)
CA (1) CA3073782A1 (enExample)
CL (1) CL2020000553A1 (enExample)
EA (1) EA202090653A1 (enExample)
IL (1) IL272923B2 (enExample)
MX (1) MX2020002505A (enExample)
PE (1) PE20200727A1 (enExample)
PH (1) PH12020500408A1 (enExample)
SG (1) SG11202001642WA (enExample)
TW (1) TWI816693B (enExample)
UA (1) UA129118C2 (enExample)
WO (1) WO2019047909A1 (enExample)
ZA (1) ZA202001448B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109467538A (zh) * 2017-09-07 2019-03-15 和记黄埔医药(上海)有限公司 环烯烃取代的杂芳环类化合物及其用途
BR112020003494A2 (pt) 2017-09-07 2020-08-25 Augusta University Research Institute, Inc composto, métodos para aumentar uma resposta imunossupressora, para tratar um distúrbio inflamatório, uma doença autoimune, doença do enxerto contra hospedeiro, infecção crônica e obesidade e para inibir ou reduzir a rejeição a um transplante, e, composição farmacêutica
CN116209655A (zh) * 2020-11-09 2023-06-02 贝达药业股份有限公司 突变型idh1和idh2抑制剂及其应用
WO2023134686A1 (zh) * 2022-01-11 2023-07-20 正大天晴药业集团股份有限公司 一种1,3,5-三嗪衍生物的制备方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3555154A (en) 1967-08-16 1971-01-12 Armour Pharma Preparations containing 6 - cycloalkylguanamines and methods for treating inflammatory conditions therewith
US5019574A (en) 1988-09-30 1991-05-28 Chugai Seiyaku Kabushiki Kaisha 3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline compounds useful for improving psychoneural function
ATE396978T1 (de) 1999-10-07 2008-06-15 Amgen Inc Triazin-kinase-hemmer
NZ551559A (en) 2004-05-24 2008-10-31 Equusys Inc Animal instrumentation
GB0512324D0 (en) * 2005-06-16 2005-07-27 Novartis Ag Organic compounds
CN101466670B (zh) 2006-04-07 2013-04-17 梅特希尔基因公司 组蛋白脱乙酰酶抑制剂
EP2066645A2 (en) * 2006-09-12 2009-06-10 UCB Pharma S.A. 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions
WO2008122378A1 (en) 2007-04-04 2008-10-16 Ucb Pharma, S.A. Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof
JO3240B1 (ar) 2007-10-17 2018-03-08 Janssen Pharmaceutica Nv c-fms مثبطات كيناز
JP2011507910A (ja) 2007-12-21 2011-03-10 ユニバーシティー オブ ロチェスター 真核生物の寿命を変更するための方法
UY32742A (es) 2009-06-25 2010-12-31 Amgen Inc Compuestos heterocíclicos y sus usos
WO2011078143A1 (ja) 2009-12-22 2011-06-30 塩野義製薬株式会社 ピリミジン誘導体およびそれらを含有する医薬組成物
WO2012003283A1 (en) 2010-06-30 2012-01-05 Amgen Inc. Heterocyclic compounds and their use as inhibitors of pi3k activity
JP6010557B2 (ja) 2011-03-02 2016-10-19 リード ディスカバリー センター ゲーエムベーハー 薬学的活性化二置換トリアジン誘導体
SI2755958T1 (sl) 2011-09-12 2017-12-29 Merck Patent Gmbh Aminopirimidinski derivati za uporabo kot modulatorji kinazne aktivnosti
SG10201606301YA (en) 2011-09-12 2016-09-29 Merck Patent Gmbh Novel imidazole amines as modulators of kinase activity
TWI547493B (zh) 2011-09-27 2016-09-01 諾華公司 作為突變idh之抑制劑之3-嘧啶-4-基-唑啶-2-酮
UA117451C2 (uk) 2012-01-06 2018-08-10 Аджиос Фармасьютікалз, Інк. Терапевтично активні сполуки і способи їх застосування
EP2912024B1 (en) 2012-10-24 2016-07-20 Basf Se Herbicidal azines
CN103044469A (zh) * 2012-11-30 2013-04-17 大连联化化学有限公司 一种制备环戊烯/环己烯-1-硼酸频哪醇酯的方法
WO2014116594A1 (en) 2013-01-23 2014-07-31 The University Of Toledo Highly selective anti-cancer agents targeting non-small cell lung cancer and other forms of cancer
WO2015003360A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
US9724350B2 (en) * 2013-07-11 2017-08-08 Agios Pharmaceuticals, Inc. N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
WO2015006591A1 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. 2,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer
CN105517996B (zh) * 2013-07-11 2019-03-26 安吉奥斯医药品有限公司 治疗活性化合物及其使用方法
CN110386922A (zh) 2013-08-02 2019-10-29 安吉奥斯医药品有限公司 治疗活性化合物及其使用方法
CA2922532C (en) 2013-11-01 2023-09-19 Novartis Ag Aminoheteroaryl benzamides as kinase inhibitors
JP6635949B2 (ja) 2014-06-04 2020-01-29 トーマス・ヘレデイズ・スティフテルス・フォー・メディシンスク・フォルスクニング 炎症性および自己免疫性の病気の処置のためのmth1阻害剤
AU2015268961B9 (en) 2014-06-04 2019-10-10 Thomas Helledays Stiftelse For Medicinsk Forskning MTH1 inhibitors for treatment of cancer
KR102303011B1 (ko) 2015-07-30 2021-09-16 치아타이 티안큉 파마수티컬 그룹 주식회사 1,3,5-트라이아진 유도체 및 이의 사용 방법
US10526309B2 (en) 2015-10-02 2020-01-07 The University Of North Carolina At Chapel Hill Pan-TAM inhibitors and Mer/Axl dual inhibitors
CA3007218A1 (en) 2015-12-04 2017-06-08 Agios Pharmaceuticals, Inc. Methods of treatment of malignancies
WO2017096945A1 (zh) 2015-12-07 2017-06-15 北京康美特科技股份有限公司 含硼有机硅化合物、太阳能电池组件用密封剂以及太阳能电池组件
JP7041070B2 (ja) 2016-04-15 2022-03-23 エピザイム,インコーポレイティド Ehmt1およびehmt2阻害剤としてのアミン置換アリールまたはヘテロアリール化合物
CN107382840B (zh) 2016-05-16 2020-09-01 四川大学 吡啶类化合物及其作为idh功能变异突变体抑制剂类药物的用途
EP3652184A4 (en) 2017-08-15 2020-05-20 AbbVie Inc. MACROCYCLIC INHIBITORS OF MCL-1 AND METHODS OF USE
CN109467538A (zh) * 2017-09-07 2019-03-15 和记黄埔医药(上海)有限公司 环烯烃取代的杂芳环类化合物及其用途
AU2018330578B2 (en) 2017-09-07 2022-11-10 Eisai R&D Management Co., Ltd. Pentacyclic compound

Similar Documents

Publication Publication Date Title
JP2020533319A5 (enExample)
RU2006125377A (ru) Гетероциклические ингибиторы аспартилпротеазы
JP2020169171A5 (enExample)
IL268030B2 (en) Bicyclic compounds as allosteric shp2 inhibitors
JP2014051526A5 (enExample)
JP2019518766A5 (enExample)
JP2004516314A5 (enExample)
JP2021500394A5 (enExample)
JP2007505902A5 (enExample)
JP2005511698A5 (enExample)
IL312845B1 (en) Extacan derivatives, charge-linkers, and their conjugates
JP2011515482A5 (enExample)
JP2010533699A5 (enExample)
JP2008510770A5 (enExample)
RU2005139398A (ru) Циклические сульфонамиды для ингибирования гамма-секретазы
JP2011520815A5 (enExample)
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2005511699A5 (enExample)
RU2006135541A (ru) Производные аминокислот
JP2005536503A5 (enExample)
JP2007514691A5 (enExample)
RU2007147344A (ru) Новые производные 2-азетидинона для лечения гиперлипидемических заболеваний
JP2010520276A5 (enExample)
IL316674A (en) History of Oxoindolinyl Amide for Inhibition of NLRP3 and Its Uses
JP2021524856A5 (enExample)